A 2024 review surveyed neurotransmitter-system interactions in this body of work (PMID 38675421), suggesting the compound's effects on central nervous system tissue may share mechanisms with its peripheral activity
The injection can be given at any time of the day, with or without meals, and should be administered on the same day each week
GLP-1 manufacturers often require a formal ophthalmological examination in their clinical trials because there is a proven small risk that these drugs might cause worsening of diabetic retinopathy
24 In this review, we discuss the benefits and challenges associated with the small-molecule GLP-1 RA drugs from pre-clinical and clinical studies
Many participants in structured programs report an average body weight loss of 15% after 68 weeks, with some achieving losses exceeding 20-25% within a year
[12] From the perspective of the patient with diabetes, weight gain and hypoglycemia are undesirable and unwanted side effects